Transcode Therapeutics (RNAZ) Shares Issued (2020 - 2026)
Transcode Therapeutics' (RNAZ) quarterly Shares Issued came in at $2035.0 in Q1 2026, down 96.41% YoY from $56668.0 in Q1 2025, and little changed on a QoQ basis from $2035.0 in Q4 2025.
Transcode Therapeutics (RNAZ) Shares Issued (2020 - 2026) Analysis & Trends
Transcode Therapeutics (RNAZ) has 7 years of Shares Issued data on file, last reported at $2035.0 in Q1 2026.
- Quarterly Shares Issued fell 96.41% year-over-year to $2035.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2035.0 (down 96.41% YoY) and the FY2025 annual result came in at $2035.0, down 3.19% from the prior year.
- Shares Issued was little changed at $2035.0 in Q1 2026, from $2035.0 in the prior quarter.
- In the past five years, Shares Issued ranged from a high of $3.0 million in Q1 2023 to a low of $85.0 in Q4 2022.
- A 5-year average of $698751.6 and a median of $5875.0 in 2024 frame the typical range for Shares Issued.
- Annual changes were most pronounced in 2024 — Shares Issued soared 2372.94% — and 2025, when it plunged 99.89%.
- Tracing RNAZ's Shares Issued over 5 years: stood at $85.0 in 2022, then changed by 0.0% to $85.0 in 2023, then soared by 2372.94% to $2102.0 in 2024, then declined by 3.19% to $2035.0 in 2025, then changed by 0.0% to $2035.0 in 2026.
- The last three Shares Issued figures came in at $2035.0 (Q1 2026), $2035.0 (Q4 2025), and $2035.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | - |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | - |
| 10 | Transcode Therapeutics | 2.84 Mn | 2.84 Mn | - | 2,035.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,035.00 |
| Mar 31, 2026 | 2,035.00 |
| Dec 31, 2025 | 2,035.00 |
| Dec 31, 2025 | 2,035.00 |
| Sep 30, 2025 | 2,035.00 |
| Sep 30, 2025 | 2,035.00 |
| Jun 30, 2025 | 2,039.00 |
| Jun 30, 2025 | 2,039.00 |
| Mar 31, 2025 | 56,668.00 |
| Mar 31, 2025 | 56,668.00 |
| Dec 31, 2024 | 2,102.00 |
| Dec 31, 2024 | 2,102.00 |
| Sep 30, 2024 | 1.92 Mn |
| Sep 30, 2024 | 1.92 Mn |
| Jun 30, 2024 | 3,247.00 |
| Jun 30, 2024 | 3,247.00 |
| Mar 31, 2024 | 5,875.00 |
| Mar 31, 2024 | 5,875.00 |
| Dec 31, 2023 | 85.00 |
| Dec 31, 2023 | 85.00 |